Aromasin (Exemestane) is officially categorized as a steroidal Suicide Aromatase Inhibitor, meaning it can effectively block the aromatase enzyme responsible for converting testosterone to estrogen. By inhibiting aromatization, Aromasin reduces estrogen production, thereby decreasing serum estrogen levels in the body. This property is beneficial for breast cancer patients, as breast cancer cells often thrive on estrogen. Additionally, it proves advantageous for anabolic steroid users looking to mitigate the side effects of testosterone aromatization.
Many anabolic steroids can elevate estrogen levels through the aromatase process, leading to issues like gynecomastia and water retention. Even steroids with low estrogenic activity, such as Nandrolone, can cause these effects due to their progestin nature. Progesterone, a hormone associated with progestin, can stimulate estrogenic mechanisms in mammary tissue. By incorporating Aromasin alongside anabolic steroid use, aromatase inhibition occurs, estrogen levels decrease, and individuals are protected from estrogen-related side effects.
Aromasin boasts an average efficacy of lowering serum estrogen levels by approximately 85%.
 
Packaging: 60 capsules in a sealed pouch.
EACH CAPSULE CONTAINS:
Exemestane
USP
12.5mg
Excipients
q.s.
 
Dosage & administration:
Half life
10 hours (male) 24 hours (female)
Dose
12.5 – 25mg per day or as required
Average Cycle Length
Throughout the length of your intended anabolic steroid cycle and or during post cycle therapy
Anabolic #
n/a
Androgenic #
n/a
Oral Bioavailability
Estimated at 60%
CAS Name
2,2′-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)[1]
Synonyms
Exemestane, Aromasin